Axel Lecesne

12PUBLICATIONS
179CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsDisease surveillanceAnaesthesiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 08, 2026
Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors from Whole-Slide Images.

|May 23, 2025
Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE.

Michael C Heinrich, Jean-Yves Blay, Hans Gelderblom

|Dec 11, 2024
A Phase I Study of FHD-609, a Heterobifunctional Degrader of Bromodomain-Containing Protein 9, in Patients with Advanced Synovial Sarcoma or SMARCB1-Deficient Tumors.

J Andrew Livingston, Jean-Yves Blay, Jonathan Trent

|Dec 02, 2024
Active Surveillance in Patients with Extra-abdominal Desmoid-Type Fibromatosis: A Pooled Analysis of Three Prospective Observational Studies.

Chiara Colombo, Stefanie Hakkesteegt, Axel Le Cesne

|Oct 16, 2024
Replication Stress Is an Actionable Genetic Vulnerability in Desmoplastic Small Round Cell Tumors.

Asuka Kawai-Kawachi, Madison M Lenormand, Clémence Astier

|Sep 12, 2023
Low-Grade Uterine Leiomyosarcoma Is Highly Sensitive to Hormonal Treatment.

Roberta Sanfilippo, Marta Sbaraglia, Chiara Fabbroni

Pageof 2

Frequent Collaborators

6 joint publications

Jean-Yves Blay

4 joint publications

Javier Martin-Broto

4 joint publications

Giovanni Grignani

3 joint publications

Albiruni Abdul Razak